Exploring the Biological Basis of Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Clinical Trial

— CHROME  

Official title:

Exploring the Biological Basis of Chronic Fatigue Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04859257
• Other study ID #: DXT-MCD-AH01
• Status: Completed
• Start date: May 26, 2021
• Est. completion date: December 1, 2021

Study information

• Verified date: February 2022
• Source: DxTerity Diagnostics
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To collect blood and urine samples from patients with Chronic Fatigue Syndrome (CFS), myalgic encephalomyelitis (ME), and SEID (Systemic Exertion Intolerance Syndrome) and controls for genomic, viral and metabolomic testing.

Description:

To analyze gene expression (genomic) and viral analysis data from patients diagnosed with ME/CFS, the study will collect blood samples (finger stick) and information from up to 500 subjects for analysis. In addition, urine will be collected for all subjects to evaluate the study subject's metabolomics. All participants will complete a single Study Collection event consisting of at least one MCD (2nd sample is optional) and one urine collection from home: 10% of each group (ME/CFS and Control) will complete a second Study Collection event approximately 1 to 2 weeks after the initial Study Collection. The second collection is to compare data between two collections from the same participants to observe any time-related changes in the results.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 380
• Est. completion date: December 1, 2021
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria: (Cohort 1)

1. Male and female patients age 18 or older at the time of consent

2. Have a permanent address in the United States for the duration of the study

3. Have an email address and access to the internet for the duration of the study

4. Able to provide unassisted informed consent

5. Medical Record Consent (optional)

6. Diagnosed with Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) OR

7. Report experiencing one or more of the following symptoms (record all that apply):

1. Greatly lowered ability to perform normal daily activities due to profound fatigue that has lasted for at least 6 months

2. Worsening of (fatigue) symptoms after physical or mental activity that would not have caused a problem before illness (post-exertional malaise).

3. Sleep Problems. Feel overly tired or unrefreshed even after a full night of sleep

4. Problems with thinking and memory (trouble thinking quickly, remembering things, paying attention to details, have "brain fog") OR

5. Worsening of symptoms while standing or sitting upright -

Exclusion Criteria:

• Pregnancy Inclusion Criteria: (Cohort 2)

1. Male and female patients age 18 or older at the time of consent

2. Have a permanent address in the United States for the duration of the study

3. Have an email address and access to the internet for the duration of the study

4. Able to provide unassisted informed consent

5. Medical Record Consent (optional)

Exclusion Criteria:

1. Pregnant

2. Diagnosed with Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) OR

3. Report experiencing one or more of the following symptoms (record all that apply):

1. Greatly lowered ability to perform normal daily activities due to profound fatigue that has lasted for at least 6 months

2. Worsening of (fatigue) symptoms after physical or mental activity that would not have caused a problem before illness (post-exertional malaise).

3. Sleep Problems. Feel overly tired or unrefreshed even after a full night of sleep

4. Problems with thinking and memory (trouble thinking quickly, remembering things, paying attention to details, have "brain fog") OR

5. Worsening of symptoms while standing or sitting upright

Related Conditions & MeSH terms

• Chronic Fatigue Syndrome
• Fatigue
• Fatigue Syndrome, Chronic
• Syndrome

Locations

Country	Name	City	State
United States	DxTerity Diagnostics Inc.	Compton	California

Sponsors (1)

Lead Sponsor	Collaborator
DxTerity Diagnostics

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Collect blood samples from patients with Chronic Fatigue Syndrome (CFS), myalgic encephalomyelitis (ME), and Systemic Exertion Intolerance Syndrome (SEID), and controls for genomic testing.	To enable research focused on discriminating differentiated symptoms of various sources of CFS from other autoimmune and viral pathogenesis of disease which could prove valuable in researching for inflammation and immunity related therapeutics.	3 months
Primary	Collect blood samples from patients with Chronic Fatigue Syndrome (CFS), myalgic encephalomyelitis (ME), and Systemic Exertion Intolerance Syndrome (SEID), and controls for viral testing.	To enable research focused on discriminating differentiated symptoms of various sources of CFS from other autoimmune and viral pathogenesis of disease which could prove valuable in researching for inflammation and immunity related therapeutics.	3 months
Primary	Collect urine samples from patients with Chronic Fatigue Syndrome (CFS), myalgic encephalomyelitis (ME), and Systemic Exertion Intolerance Syndrome (SEID), and controls for metabolomic testing.	To enable research focused on discriminating differentiated symptoms of various sources of CFS from other autoimmune and viral pathogenesis of disease which could prove valuable in researching for inflammation and immunity related therapeutics.	3 months